Drugs & Pharmaceuticals

In the next few weeks, we will experience the downside risks of offshoring. Moving manufacturing to areas with specialized expertise should reduce costs and provide a better product.

On March 23 Arizona Governor Doug Ducey sent a letter to Seema Verma, Administrator of the Centers for Medicare and Medicaid Services, informing

Within the coming weeks, we should be starting to get a picture of whether remdesivir will be a savior to the world, just another failed drug, or something in between.

Coronaviruses are a large family of viruses that cause disease in animals and humans.

Two drugs, chloroquine (CQ), and hydroxychloroquine (HCQ) are all over the news because both drugs are being extensively studied for their antiviral potential against coronavirus.

You just can't hype drugs. They are either going to work well or not. Wishful thinking doesn't help. Neither does bluster. Nonetheless, we're now getting quite a dose of hype and bluster in recent days.

There is now a potentially important change in the pharmaceutical landscape of anti-coronavirus drugs.

Even if an effective vaccine for the Wuhan coronavirus is discovered, which is by no means a certainty, it will be at least a year (more likely two) before you'll be rolling up your sleeve.

The New York Times recently published a disturbing report about life‐​threatening errors made by overworked pharmacists, m

If there is a single company that tops the "no good deed goes unpunished" contest I would pick Gilead Sciences. By a mile.